Thermo Fisher to buy data solutions-focused Clario for up to $9.4Bnews2025-10-29T18:49:39+00:00October 29th, 2025|Endpoints News|
GSK confirms it has completed IRA negotiations ahead of CMS deadlinenews2025-10-29T17:54:46+00:00October 29th, 2025|Endpoints News|
Lilly budgets $1.2B for GLP-1 pill factory in Puerto Rico news2025-10-29T17:38:18+00:00October 29th, 2025|Endpoints News|
Ventus stops Phase 2 of NLRP3 inhibitor that was being tested in Parkinson’snews2025-10-29T17:05:59+00:00October 29th, 2025|Endpoints News|
FDA to reduce regulatory red tape for biosimilarsnews2025-10-29T16:43:48+00:00October 29th, 2025|Endpoints News|
After this year’s Nobel Prize, the first results for a CAR-Treg for autoimmune disease are innews2025-10-29T15:31:04+00:00October 29th, 2025|Endpoints News|
What Novo Nordisk might be planning to turn the ship aroundnews2025-10-29T15:23:20+00:00October 29th, 2025|Endpoints News|
Novo Nordisk’s direct-to-patient platform gains momentum as self-pay sales risenews2025-10-29T15:23:01+00:00October 29th, 2025|Endpoints News|
Kyverna says small group of rare disease patients all responded to its CAR-Tnews2025-10-29T14:44:27+00:00October 29th, 2025|Endpoints News|
Recursion gets $30M from Roche; Chinese siRNA biotech to go public in Hong Kong news2025-10-29T14:32:31+00:00October 29th, 2025|Endpoints News|
